Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
With the improving pricing scenario in the insurance market and supported by RLI Corp.’s (RLI - Analyst Report) strong infrastructure, we expect the company to perform well in the upcoming quarters. Also, the company has a favorable loss reserve ratio compared with the previous year along with increasing statutory reserve. Moreover, RLI Corp. scores strongly with the rating agencies.
However, continued low interest rate environment keeps us on the sidelines. We retain our Neutral recommendation on the company.
RLI Corp. is one of the industry’s most profitable P&C writers, having generated underwriting profits in 31 of the last 35 years, including the last 16 consecutive years. With the expansion of its business, the company’s gross premium written increased almost 15% to $405.9 million in the second quarter of 2012.
The company maintains a conservative underwriting and reserving policy and continues to achieve favorable reserve releases from prior years. Its statutory surplus levels are also strong and exhibit an increasing trend.
RLI Corp. remains focused on enhancing shareholder value. Following a dividend hike of 6.7%, dividend yield came in at 3.00%, higher than the 2.1% of the S&P index. Additionally, it is still left with $87.5 million available under its authorization. Over the last five years, RLI Corp. paid back more than $700 million to its shareholders through dividends, special dividends and share buybacks.
The company also scores strongly with the rating agencies. Recently, A.M. Best Co. reaffirmed its financial strength rating on the subsidiaries.
On the flip side, low interest rate environment continues to weigh on net investment income and the recent quarter was no exception. The quarter marked a decline in net investment income largely due to lower reinvestment rates in the fixed income portfolio.
Also, RLI Corp. continues to suffer from the overhang of cat losses. The combined ratio for the second quarter of 2012 deteriorated to 84.7% from 67.8% in the year-ago quarter. However, the company, by purchasing reinsurance, limits its loss.
The Zacks Consensus Estimate for third-quarter 2012 is pegged at 94 cents per share. For full years 2012 and 2013, the Zacks Consensus Estimates are, respectively, $4.06 and $4.20 per share.
The quantitative Zacks #3 Rank (short-term Hold rating) on the stock indicates no clear directional pressure over the near term. ACE Limited (ACE - Analyst Report) and The Travelers Companies, Inc. (TRV - Analyst Report) which competes with RI Corp. also share a Zacks #3 Rank.
Get the full Analyst Report on RLI - FREE
Get the full Analyst Report on TRV - FREE
Get the full Analyst Report on ACE - FREE